More than 400 000 low-income beneficiaries may have missed out on millions of dollars in federal subsidies to help pay for prescription drug purchases under Medicare Part D, said a report released by the Government Accountability Office on May 8.
The report, compiled at the request of Sen Max Baucus (D, Mont), chairman of the Senate Finance Committee, said the Centers for Medicare & Medicaid Services (CMS), failed to notify “dual-eligible” beneficiaries (those qualifying for Medicare and Medicaid) that they were eligible for reimbursement on previous prescription drug purchases when they began the enrollment process for Medicare Part D but had not yet been formally approved—a process that takes a minimum of 5 weeks.
Mitka M. Drug Reimbursements. JAMA. 2007;297(22):2465. doi:10.1001/jama.297.22.2465-c